Recruiting OBSERVATIONAL NCT04834869

COVID-19 Vaccines Safety Tracking (CoVaST)

COVID-19 Vaccines Safety Tracking: Global Consortium Study

Sponsor: Masaryk University

Conditions Adverse Reaction to Vaccine COVID19 Vaccine

Interventions AZD1222 BBV152 BNT162b2 CVnCoV CoronaVac Gam-COVID-Vac JNJ-78436735 NVX-CoV2373 Sinopharm mRNA-1273

Updated 7 times since 2021 Last updated: Apr 5, 2022 Started: Apr 1, 2021 Primary completion: Dec 31, 2025 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Adverse Reaction to Vaccine and COVID19 Vaccine and is currently actively recruiting participants. Masaryk University leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Recruiting
Sep 2024 — Sep 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
May 2022 — Jul 2024 [monthly]

Recruiting
Nov 2021 — May 2022 [monthly]

Recruiting

▶ Show 2 earlier versions

Sep 2021 — Nov 2021 [monthly]

Recruiting
May 2021 — Sep 2021 [monthly]

Recruiting

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Masaryk University

Data source: Masaryk University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Accra, Ghana , Belgrade, Serbia , Brno, Czechia , Coimbra, Portugal , Culiacán, Mexico , Giessen, Germany , Hamilton, Canada , Irkutsk, Russia , Jimma, Ethiopia , Katowice, Poland and 4 more locations